Clinical Trials
5 trialsNCT02858310 2026-03-09
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT05035407 2025-12-02
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT06111872 2025-03-25
Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.
National University of Malaysia
Phase 2 Completed
NCT02684942 2017-06-01
Comparison of Meperidine and Fentanyl on Pain Scale and QOL in Brachytherapy
Chulabhorn Cancer Center
Phase 4 Completed
NCT02027311 2015-06-29
Etomidate vs. Midazolam for Sedation During ERCP
Cheju Halla General Hospital
Phase 4 Completed